Immunoglobulin (Ig) Therapy

A guide for patients

Your doctor has referred you for immunoglobulin therapy. This leaflet explains:

If after reading this leaflet you have any questions or concerns, please speak to your specialist nurse or the contact given to you by your specialist.

Patients may need immunoglobulin therapy for many reasons. Your doctor will have discussed your particular situation with you.

What is immunoglobulin and what are antibodies?

Who needs treatment with Ig?

Ig therapy is often used for people who cannot make their own antibodies. This causes them to have infections due to a weakened immune system. This is called Ig replacement therapy. It can be a short-term or long-term treatment, depending on the reason you are having the therapy. How long you need to have Ig therapy will be discussed with your doctor.

Ig therapy is also used to treat conditions where the immune system is overactive. The mixture of antibodies in the Ig preparation calms down the person’s immune system. This treatment is usually given in hospital after a thorough medical assessment.

If you are not sure why you need Ig treatment, or have any questions, please speak to your doctor.

What is the treatment?

How is the treatment given?

Ig treatment comes as a liquid and is injected either:

Intravenous is commonly used in hospital. Whereas, for long-term conditions, subcutaneous can be used. 

Can I give this treatment myself at home?

For long-term conditions, many patients can be trained to give their own Ig treatment at home. However, not everyone is suitable for home therapy.

If you would like to discuss home therapy, please speak to your nurse or doctor.

Could there be any problems with Ig therapy?

As with all medicines, there are some potential risks associated with treatment, but serious problems are rare. We outline some of the potential risks of Ig therapy below. 

  1. Infusion reactions

    You may feel unwell during or soon after your infusion. Most of these reactions are mild but they might be unpleasant for a while. If you do experience any side effects of treatment, let a member of the team know immediately.

    • Mild reactions include headache, flushing, fever or shivering, rash, back pain. About 1 in 10 patients may have these. They are usually easy to control and not harmful.

    • Moderate reactions include chest pain, vomiting, dizziness, severe headache.

    • Severe reactions include acute severe wheezing, swelling of face, neck or tongue, difficulty swallowing or breathing, faintness or unconsciousness.

    Moderate and severe reactions are very rare, but you still need to know what to look out for. Tell your specialist nurse or the contact given to you by your specialist, if you have any symptoms or concerns. They can then reassure or treat you as necessary.

  2. Transmission of blood-borne infections

    Ig is made from donated blood, so there is a risk that an infection can transfer from a donor to the person receiving Ig. There are many steps in the manufacturing process that minimise this risk.

    • Blood donors are screened on their personal and medical history, and through blood tests.

    • A donated blood unit is only used after the donor has attended again for another donation, and is still well.

    • Often, manufacturers only take blood from donors they have known for a long time. Who they know have normal tests over an extended period.

    • Many of the steps in the manufacturing process kill viruses.

    • Doctors review the available Ig preparations. They then decide which ones to recommend and use. This includes reviewing their safety record, and details of their manufacturing processes.

    These safety steps help to minimise the risk of transmitting:

    • infections we know about (like hepatitis), and

    • infections we may discover in the future.

  1. Other rare side effects (affects between 1 in 10,000 and 1 in 1,000 people)

    • Kidney failure. Ig treatment can affect your kidneys. This would be found when you have blood tests after your treatment. It does not usually cause any symptoms.

    • Haemolytic anaemia. The Ig product reacts with and damages the patient’s red blood cells. This might cause a mild infusion reaction, and show up as anaemia on a blood test.

    • Thrombosis. Patients on Ig therapy have a slightly increased risk of suffering blood clots. This could include a heart attack, stroke or blood clots in the lung or legs. Whilst potentially serious, the risk of these is very low. 

      It is important to drink plenty of water before your infusion, to reduce your risk of developing a blood clot. Keeping active before and after treatment will also help.

      For more information, please ask a member of staff for the Trust’s Preventing a blood clot whilst you are in hospital leaflet.

    • Immunoglobulin therapy can very rarely cause severe allergic reactions.

If you experience any of the risks listed above, please speak to your specialist nurse or the contact given to you by your specialist. In an emergency, call 999.

Other questions

Where can I get more information?

If you have any questions or concerns, please speak to your specialist nurse or the contact given to you by your specialist. Please feel free to ask us any questions you have.

The following web sites have useful information about immune deficiency and immunoglobulin therapy.